BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 32582698)

  • 1. Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy.
    Chulpanova DS; Kitaeva KV; Green AR; Rizvanov AA; Solovyeva VV
    Front Cell Dev Biol; 2020; 8():402. PubMed ID: 32582698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Development Status of Cytokines for Cancer Immunotherapy.
    Song K
    Biomol Ther (Seoul); 2024 Jan; 32(1):13-24. PubMed ID: 38148550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer.
    Kourko O; Seaver K; Odoardi N; Basta S; Gee K
    Front Oncol; 2019; 9():969. PubMed ID: 31681561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
    Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
    Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy.
    Mao C; Ding Y; Xu N
    Front Oncol; 2021; 11():688489. PubMed ID: 34868907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
    Vijayakumar G; McCroskery S; Palese P
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1 cytokine-based immunotherapy for cancer.
    Xu HM
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):482-94. PubMed ID: 25308358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
    Xiang J
    Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
    Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
    Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-based therapy and biochemotherapy for advanced melanoma.
    Atkins MB
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2353s-2358s. PubMed ID: 16609058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.
    Ganea D
    Adv Neuroimmunol; 1996; 6(1):61-74. PubMed ID: 8790782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
    Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
    Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 26. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodies.
    Nelson RP; Ballow M
    J Allergy Clin Immunol; 2003 Feb; 111(2 Suppl):S720-43. PubMed ID: 12592317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine therapy for cancer.
    Tagawa M
    Curr Pharm Des; 2000 Apr; 6(6):681-99. PubMed ID: 10788604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.